reporting rate of discarded cases* per 100'000 population**

Slides:



Advertisements
Similar presentations
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.
Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.
1 |1 | Countries using and planning to introduce IPV.
Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.
Vaccine in National Immunization Programme Update March 2015.
1 |1 | Countries using and planning to introduce IPV.
1 |1 | Countries using and planning to introduce IPV.
World Health Organization
TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *
WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.
The Global Plan to Stop TB, (1)
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
World Health Organization
Reaching the 2010 Measles Mortality Reduction Goal-can SEARO get there? Meeting of the Partners for Measles Advocacy Washington DC, September 2008.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.
Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.
Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.
WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.
Sustaining the gains and reaching milestones on the way towards elimination of measles and rubella 15 September 2015 Dr Peter Strebel, WHO, IVB/EPI.
Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.
Vaccine in National Immunization Programme Update April 2016.
World Health Organization
SAGE 2010 Sampling Distribution
2016 Immunization Coverage Data at Subnational Level
financial requirements
Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.
Ageing Matters Somnath Chatterji Information, Evidence and Research
World Health Organization
PROGRESS IN GLOBAL TB CONTROL
Session 1: New Opportunities and New Direction
World Health Organization
Monthly Distribution of Wild Poliovirus Cases1,
SAGE 2009 Sampling Distribution
World Health Organization
06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries Having Introduced Hib Vaccine
Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010
Sampling Distribution
15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016
Monthly Distribution of Wild Poliovirus Cases1,
(70 countries or 36%) (23 countries or 12%)
Countries with Genotype data available
Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.
World Health Organization
24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
World Health Organization
Onset of most recent WPV1 Case Number of WPV infected districts
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Countries having introduced HepB vaccine
No new positives this week
05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
Most-affected regions in the Russian Federation
08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.
Distribución de los genotipos de rubéola notificados a la OMS
Mapping Levels of Palliative Care Development: A Global Update
Countries Using Mening Vaccine in National Immunization Schedule 2011
- Use same categories as for bar chart below Introduced Without GAVI
Onset of most recent case Number of infected districts
PROGRESS IN GLOBAL TB CONTROL
04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.
THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION
Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.
16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.
2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)
World Health Organization
Attachment B-3: Animation of 137Cs deposition on ground/sea surface
World Health Organization
Presentation transcript:

Measles1 Surveillance System Sensitivity Oct 2015 to Sep 2016 (12M period) reporting rate of discarded cases* per 100'000 population** Eliminated countries are not maintaining sensitive surveillance Target: at least 2 discarded cases per 100'000 population by country in last 12 month period. *discarded cases are suspected measles cases which have been investigated and discarded as non-measles cases using laboratory testing and/or epidemiological-linkage. ** World population prospects, 2015 revision . 1 In the Region of the Americas, this surveillance is integrated with rubella. ≥2 (67 countries or 41%) >1 - <2 (35 countries or 22%) ≤1 (50 countries or 31%) No case based surveillance or No or insufficient data reported on discarded cases No case based surveillance or No or insufficient data reported (10 countries or 6%) Not applicable The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. ©WHO 2016. All rights reserved. Data source: surveillance DEF file Data in HQ as of 9 November 2016